title: Chloride-Inducible Expression Vector for Delivery of Antimicrobial Peptides Targeting Antibiotic-Resistant Enterococcus faecium.
abstract: Antibiotic-resistant enterococcal infections are a major concern in hospitals where patients with compromised immunity are readily infected. Enterococcus faecium bacteria are of particular interest as these pathogens account for over 80% of vancomycin-resistant enterococcal infections. Antimicrobial peptides (AMPs) produced at the site of infection by engineered bacteria may offer a potential alternative to traditional antibiotics for the treatment of resistant bacteria such as E. faecium. For this mode of delivery to be effective, it is essential to identify a suitable protein expression system that can be used in the desired delivery bacterium. In this study, we describe a promising chloride-inducible promoter and its application in the bacterial delivery of AMPs from Lactococcus lactis to reduce counts of E. faecium bacteria in vitro. Reporter gene studies show that at chloride concentrations found within the human intestines, the chloride-inducible promoter exhibits high levels of protein expression compared to those of the commonly used nisin-inducible promoter. These results indicate that this system is powerful and would not require the exogenous administration of an inducer molecule. In its application for AMP production against E. faecium in vitro, L. lactis producing AMPs under the chloride promoter rapidly decreased E. faecium counts by nearly 10,000-fold. As an extension of this application, we also demonstrate the potential in using this type of delivery system in combination with traditional antibiotics to slow the development of resistance. Collectively, this study shows the promise of using a chloride-inducible promoter for the bacterial delivery of AMPs in the body for the treatment of vancomycin-resistant enterococci (VRE) and other antibiotic-resistant bacteria.
authors.affiliation: Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.
authors.forename: Kathryn
authors.initials: K
authors.lastname: Geldart
authors.affiliation: Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.
authors.forename: Juan
authors.initials: J
authors.lastname: Borrero
authors.affiliation: Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA yiannis@umn.edu.
authors.forename: Yiannis N
authors.initials: YN
authors.lastname: Kaznessis
mesh_terms: D000898:Antibiosis; D023181:Antimicrobial Cationic Peptides / Q000235:genetics / Q000378:metabolism*; D058491:Bacterial Load; D002712:Chlorides / Q000378:metabolism*; D016984:Enterococcus faecium / Q000187:drug effects*; D015964:Gene Expression Regulation, Bacterial / Q000187:drug effects; D005822:Genetic Vectors; D006801:Humans; D013294:Lactococcus lactis / Q000235:genetics* / Q000378:metabolism*; D008826:Microbial Sensitivity Tests; D011401:Promoter Regions, Genetic; D015533:Transcriptional Activation / Q000187:drug effects*
chemical_list: D023181:Antimicrobial Cationic Peptides; D002712:Chlorides
references.citation: Am J Dig Dis. 1966 Jul;11(7):503-21
references.pmid: 5937767
references.citation: Mol Microbiol. 2004 Oct;54(2):520-32
references.pmid: 15469521
references.citation: Methods Mol Biol. 1995;47:195-9
references.pmid: 7550735
references.citation: Antimicrob Agents Chemother. 1996 Aug;40(8):1801-5
references.pmid: 8843284
references.citation: Antimicrob Agents Chemother. 1996 Mar;40(3):646-51
references.pmid: 8851587
references.citation: Appl Environ Microbiol. 1997 Dec;63(12):4877-82
references.pmid: 9406408
references.citation: Mol Microbiol. 1998 Jan;27(2):299-310
references.pmid: 9484886
references.citation: Indian J Med Microbiol. 2005 Oct;23(4):214-9
references.pmid: 16327115
references.citation: Clin Gastroenterol Hepatol. 2006 Jun;4(6):754-9
references.pmid: 16716759
references.citation: BMC Microbiol. 2010;10:224
references.pmid: 20738841
references.citation: Appl Environ Microbiol. 2011 May;77(10):3335-42
references.pmid: 21421780
references.citation: Int J Mol Sci. 2011;12(9):5971-92
references.pmid: 22016639
references.citation: Microbiology. 2011 Dec;157(Pt 12):3256-67
references.pmid: 21980118
references.citation: Nat Rev Microbiol. 2012 Apr;10(4):266-78
references.pmid: 22421879
references.citation: Clin Infect Dis. 2012 Apr;54 Suppl 3:S233-8
references.pmid: 22431854
references.citation: Nat Rev Drug Discov. 2013 May;12(5):371-87
references.pmid: 23629505
references.citation: J Clin Microbiol. 2000 Feb;38(2):724-6
references.pmid: 10655374
references.citation: ACS Synth Biol. 2015 Mar 20;4(3):299-306
references.pmid: 24896372
references.citation: ACS Synth Biol. 2013 Nov 15;2(11):643-50
references.pmid: 23808914
references.citation: Appl Environ Microbiol. 2002 Jun;68(6):3166-8
references.pmid: 12039786
references.citation: Appl Environ Microbiol. 2002 Nov;68(11):5223-30
references.pmid: 12406708
references.citation: J Antimicrob Chemother. 2004 Mar;53(3):530-2
references.pmid: 14963062
references.citation: Appl Environ Microbiol. 1995 Jul;61(7):2771-4
references.pmid: 7618890